906 results found.
                    
FDA Approves Expanded 26-week Efficacy Claim for Gel-One to Knee OA Pain
Zimmer Biomet announced FDA approval of an expanded 26-week efficacy claim for single-injection Gel-One
First US Implant of Vericel's MACI
Vericel announced the first U.S. implant of MACI® autologous cultured chondrocytes for the treatment of symptomatic knee cartilage defects.
BioPoly Granted Two New US Patents
BioPoly was granted two additional U.S. patents addressing its material, orthopaedic devices and methods of implantation. 
Stryker Reports 2016 Revenue
ORTHOWORLD estimates Stryker’s 2016 orthopaedic revenue at US $6,330.8MM, +4.9% from 2015, with 4Q16 revenue of $1,686.5MM, +6.5%
DePuy Synthes 2016 Revenue
DePuy Synthes posted 2016 orthopaedic revenue of US $9,003.5MM, +0.8% vs. 2015, with 4Q16 revenue of $2,302.8MM, -1.5%
DePuy Synthes Agreement with Pacira Pharmaceuticals
DePuy Synthes entered into an exclusive agreement with Pacira Pharmaceuticals for U.S. co-promotion of EXPAREL
Bovie Medical Enters Sales Partnership with ConMed
Bovie Medical entered into a global sales channel partnership agreement with CONMED for its PlazXact™ A...
Implanet Reports 2016 and 4Q16 Revenue
Implanet posted 2016 revenue of €7.8MM (~US $8.6MM), +17.6% vs. 2015, with of 4Q16 revenue of
New Durolane Agreement in Russia
Bioventus selected MEDSERVICE to distribute DUROLANE® single-injection joint fluid in Russia. 
CyMedica Orthopedics Receives FDA Clearance for e-vive Therapy
CyMedica Orthopedics received FDA 510(k) clearance for e-vive™, an app-controlled, data-driven mus...
Histogenics' NeoCart Phase I/Phase II Clinical Trial Data
Results from Phase I and Phase II study indicate that Histogenics' NeoCart® tissue-engineered implant is a safe, effective treat...
Orthocell Collaborates with Johnson & Johnson Innovation
Orthocell entered into a research collaboration agreement with DePuy Synthes Products for the Ortho-ATI®...
Zimmer Biomet Resolves Anti-Bribery Matters with DOJ and SEC
Zimmer Biomet (ZBH) concluded agreements with the U.S. DOJ and SEC to resolve previously-disclosed matters involving
Cartiva Secures $8.5MM Funding
Cartiva secured US $8.5MM in a Series E financing. Proceeds will support commercialization of the Synthetic Cartilage Impl...
CartiHeal Performs First Clinical Cases with New Unicondylar Implant
CartiHeal announced initial cases in Europe with the next-gen version of the Agili-C™ u...
Positive Long-Term Follow-Up Data for InSpace System
Long-term follow-up study results indicate that patients with massive rotator cuff tears that were treated with the OrthoSpace InSpace
Draft Guidance Announced: 510(k) Submissions for Bone Anchors
FDA released draft guidance on Premarket Notification (510(k)) Submissions for Bone Anchors.
FDA Approves Investigational Device Exemption for Agili-C Implant
CartiHeal received FDA approval of its Investigational Device Exemption application submitted for the A...
Anika Gains CE Mark Approval for ORTHOVISC-T
Anika Therapeutics received CE Mark approval for ORTHOVISC®-T injection indicated to relieve pain and rest...
Study Results: InSpace in the Treatment of Massive Rotator Cuff Tears
Initial study results indicate that patients undergoing the InSpace™ procedure to treat massive rotator cuff tear...
Vericel's Proposed Public Offering of Common Stock
Vericel intends to sell shares of common stock in an underwritten public offering.
Study Results: OrthoTrophix TPX-100 in Knee OA
OrthoTrophix announced results of the first proof of principle study of TPX-100 in bilateral knee osteoar...
Zimmer Biomet Updates: Product Supply Matters, Form 483
Zimmer Biomet reports that most product lines impacted by previously-disclosed shipping delays have returned to full ...
FDA Approves Vericel's MACI for Treatment of Adult Symptomatic Knee Cartilage Defects
FDA approved Vericel's MACI® for the repair of adult symptomatic single or multiple full-thickness cartilage defects
New DUROLANE Agreement
Bioventus entered into an agreement with Galderma to bring DUROLANE knee osteoarthritis treatment to the U.S.
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group